000100.KS
Yuhan Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 81,400.00
+0.12%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- KRW 328
- Revenue estimate
- KRW 597.9B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- KRW 869
- EPS estimate
- KRW 681
- Revenue actual
- KRW 639.5B
- Revenue estimate
- KRW 622.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +27.5%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026